BA vs DHR: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
The Boeing Company · Industrials
$234.54
+45.0% upside to fair value
Grade C
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
BA has more upside to fair value
(+45.0%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
DHR |
| Current Price |
$234.54 |
$195.98 |
| Fair Value Estimate |
$340.08 |
$211.54 |
| Upside to Fair Value |
+45.0%
|
+7.9%
|
| Market Cap |
$184.9B |
$138.7B |
| Forward P/E |
96.9x
|
37.8x
|
| EV / EBITDA |
30.4x
|
22.8x
|
| Price / Sales |
2.0x
|
5.6x
|
| Price / FCF |
-177.6x
|
26.2x
|
| Revenue Growth YoY |
+14.0%
|
+3.7%
|
| Gross Margin |
4.8%
|
60.7%
|
| Operating Margin |
-5.9%
|
21.0%
|
| Return on Equity |
-8723.1%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
The Boeing Company operates in the Industrials sector within the Aerospace & Defense industry, manufacturing commercial jetliners, defense, space, and security systems. Despite a challenging operating margin of -5.9% and a negative free cash flow per share of -2.46, Boeing shows strong recent earnings growth of 89.2% and revenue growth of 14.0% in the most recent quarter, signaling a potential re…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
BA |
DHR |
| Zone Low |
$255.06 |
$158.66 |
| Zone High |
$289.07 |
$179.81 |
| In Buy Zone? |
Yes
|
No
|